The analysis examines the historical and forecast performance for Mylan in the generic prescription pharmaceutical sector. The profile encompasses global company strategy and assessment of financial performance.
Features and benefits
- Gain insight in to Mylan's stategic outlook across the next 6 years. - Analyze company sales forecasts by therapy area, geography and formulation.
Highlights
Strategic insight into the prospects for Mylan over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales
Your key questions answered
- Benchmark Mylan's performance against key rivals in the generic prescription pharmaceutical sector. - See how the acquisition of Merck KGaA's generics unit continues to re-shape Mylan's business
